News

Mitralign, transcatheter triscupid repair, TTVR, TR, first in human

A detailed reporting of the first successful case of a direct transcatheter tricuspid repair (TTVR) for severe TR has been reported by Prof. J. Schofer, M.D., of the Medicare Center and Department...

Mitraclip, abbott, mitral valve repair, ACC, transcatheter mitral valve repair

The commercial track record with transcatheter mitral valve repair, approved for patients at high risk for surgery, compares favorably with pre-approval reports, according to findings from a U.S....

The sixth Image Wisely Radiation Safety Case —Optimizing Radiation Use During a Difficult IVC Filter Retrieval — is now available to help radiologists, imaging technologists and medical...

dual antiplatelet therapy, DAPT, mortality, DES implantation, CRF, length

Data from a meta-analysis published recently in The Lancet found that extended-duration dual antiplatelet therapy (DAPT) after drug-eluting stent (DES) implantation was associated with...

ST2, cardiac biomarker, Critical Diagnostics, heart failure, predict outcomes

According to an abstract presented at the American College of Cardiology (ACC) Scientific Sessions in San Diego, elevated levels of the cardiac biomarker ST2 were associated with an increased risk...

Emblem S-ICD, implantable cardioverter defibrillator, Boston Scientific, FDA, CE

Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) and CE Mark approval of the Emblem Subcutaneous Implantable Defibrillator (S-ICD) system. The Emblem S-ICD system is a...

IntelliSpace Cardiovascular, Philips, CVIS, cardiac PACS

Philips Healthcare launched IntelliSpace Cardiovascular at the American College of Cardiology (ACC) 2015 meeting. The Web-enabled cardiovascular information system (CVIS) offers a single...

CTA, CCTA, CT angiography, ACC.15, ACC 2015, SCOT-HEART

Use of computed tomography coronary angiography (CTA), which provides 3-D images of the heart, coupled with standard care allows doctors to more accurately diagnose coronary artery disease in...

TriGuard, Keystone, embolic protection, TAVR

March 19, 2015 — An investigational device that deflects debris away from the brain during transcatheter aortic valve replacement (TAVR) seems to improve in-hospital safety outcomes and cognitive...

CTSN, atrial fibrillation, surgical ablation, mitral valve surgery

New study results from The Cardiothoracic Surgical Trials Network (CTSN) show the addition of surgical ablation during mitral valve surgery reduces the occurrence of atrial fibrillation in...

SecondOpinionExpert, eHealth Records, mobile app

SecondOpinionExpert has expanded its online medical second opinions platform by launching an electronic health record (EHR) mobile app for iPhone, iPad and Android devices.

MPTronic, SST Group, RDM, Radiation Dosage Monitor

SST Group Inc. announced a partnership with MPTronic to become the exclusive distributor in the United States and Canada for MPTronic's RDM (Radiation Dosage Monitor).

NorthStar, RadioGenix, isotopes, separation system, Tc-99m

NorthStar Medical Radioisotopes LLC will unveil the commercial model of its RadioGenix isotope separation system during three events on March 27 and March 28 at The Keating Hotel in San Diego. The...

Sterne Agee, ACC, Medtronic, Edwards, St. Jude, TAVR, heart failure

The American College of Cardiology (ACC) hosted its 64th Annual Scientific Session & Expo over the weekend in San Diego, California. Key data from multiple transcatheter aortic valve...

CoreValve, high risk study, TAVR, Medtronic, ACC

Medtronic plc unveiled new two-year data from the CoreValve U.S. Pivotal High Risk Study, which demonstrated superior two-year survival benefits from transcatheter aortic valve replacement (TAVR)...

Edwards, Sapien, PARTNER trial, five-year outcomes, ACC

Five-year data suggest that the Sapien transcatheter heart valve (Edwards Lifesciences) is a feasible option for patients with severe aortic stenosis deemed to be at high risk for open-heart...

St. Jude, CardioMEMS, CHAMPION trial, heart failure, reduced ejection fraction

Heart failure patients with reduced ejection fraction experienced significant HF mortality and hospitalization reductions via guideline-directed medical therapy managed by pulmonary artery...

Minneapolis Heart Institute Foundation, PCI, STEMI, late presenters

New research from the Minneapolis Heart Institute Foundation (MHIF) finds that percutaneous coronary intervention for heart attacks can still be beneficial for patients who get to their more than...

Computed tomography, coronary CT angiography, PROMISE trial, ACC

Results from the PROMISE clinical trial confirmed what many cardiologists and radiologists have long suspected to be true: Coronary computed tomographic angiography (coronary CTA) is...

Medtronic, Drug Filled Stent, clinical trial, ACC

Medtronic plc unveiled the preclinical outcomes of its novel Drug-Filled Stent (DFS) at the 64th Annual Scientific Session of the American College of Cardiology (ACC). The preclinical data showed...